News
Language
Deals
Literature
CD DVD Blu ray
Ulm
local news
Live Cam
Radio
map
Fun
Tetris
Super Mario
Triviador
Checkers
2048
Dog Simulator
Sudoku
Mahjong
Trips
Medicine
EKM
GTE
Anatomy
Mathematics
CAS
Calculator
Physics
Astrophysics
Contact
Imprint
Ulm
English
en
Deutsch
de
Français
fr
News
Language
Deals
Literature
CD DVD Blu ray
Ulm
local news
Live Cam
Radio
map
Fun
Tetris
Super Mario
Triviador
Checkers
2048
Dog Simulator
Sudoku
Mahjong
Trips
Medicine
EKM
GTE
Anatomy
Mathematics
CAS
Calculator
Physics
Astrophysics
Contact
Imprint
English
en
Deutsch
de
Français
fr
EKM WS18 Introduction to Clinical Medicine
GTE Historical development of medicine
Medicine
Button
Robert Koch Institute
Red List
Pub Med
Dolosys
Cardiology
NOV
14
Improving English proficiency for scientific communication by non-fluent speakers
By:
Dong Zhao
on
NOV
14
Nature Reviews Cardiology, Published online: 14 November 2024; doi:10.1038/s41569-024-01102-1English has long been the dominant language in scientific communication. Although having a universal language for scientific communication is beneficial, this standard imposes a considerable barrier for researchers who do not speak English fluently. However, the current generation of scientists is overcoming this barrier through the use of artificial intelligence-based language tools.
Read more >>
NOV
14
Trade-offs between vessel-based and substrate-based nomenclatures for coronary heart diseases
By:
Robert A. Byrne
on
NOV
14
Nature Reviews Cardiology, Published online: 14 November 2024; doi:10.1038/s41569-024-01099-7Debate exists regarding the best terminology for common presentations of heart diseases caused by epicardial and/or microvascular coronary artery disease with or without myocardial ischaemia. In this Comment, we discuss the pros and cons of a new proposal to replace the vessel-based nomenclature of acute and chronic coronary syndromes with the myocardial-oriented nomenclature of acute and non-acute myocardial ischaemic syndromes.
Read more >>
NOV
14
Monocytes migrate to the brain after MI to promote deep sleep to aid cardiac healing
By:
Irene Fernández-Ruiz
on
NOV
14
Nature Reviews Cardiology, Published online: 14 November 2024; doi:10.1038/s41569-024-01106-xAfter myocardial infarction, monocytes are actively recruited to the brain to augment sleep power and abundance, which in turn helps to limit cardiac inflammation and promotes recovery.
Read more >>
NOV
13
Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
By:
Joel M. Gelfand
on
NOV
13
Nature Reviews Cardiology, Published online: 13 November 2024; doi:10.1038/s41569-024-01097-9In this Review on cardiodermatology, Gelfand and colleagues discuss specific skin findings associated with cardiovascular diseases, important cutaneous adverse effects of common cardiovascular therapies, and the effects of dermatological diseases and dermatological treatment on cardiovascular risk.
Read more >>
NOV
06
Our revered and mysterious heart
By:
Philip Kilner
on
NOV
06
Nature Reviews Cardiology, Published online: 06 November 2024; doi:10.1038/s41569-024-01096-wA review of Robin Choudhury’s book The Beating Heart: The Art & Science of Our Most Vital Organ, which explores depictions and perceptions of the heart across millennia.
Read more >>
NOV
05
Nanomedicine-based strategies for the treatment of vein graft disease
By:
Zhuoming Zhou
on
NOV
05
Nature Reviews Cardiology, Published online: 05 November 2024; doi:10.1038/s41569-024-01094-yIn this Review, Tao and colleagues discuss the design and applications of nanoparticles and nanofabricated biomaterials, such as hydrogels, external graft support devices and cell-based therapies, for the treatment of vein graft disease and highlight the potential of using these nanofabricated biomaterials alongside bypass surgery to improve local delivery efficiency and therapeutic efficacy.
Read more >>
OCT
25
Environmental sustainability in cardiovascular practice: current challenges and future directions
By:
Sanjay Rajagopalan
on
OCT
25
Nature Reviews Cardiology, Published online: 25 October 2024; doi:10.1038/s41569-024-01077-zIn this Review, Rajagopalan and colleagues summarize the sources of greenhouse gas emissions related to the provision of cardiovascular health care and suggest strategies to reduce carbon emissions and costs, including the use of renewable energy, waste reduction and disease prevention.
Read more >>
OCT
23
OpenEP and EP Workbench for electrophysiology data analysis
By:
Neil Bodagh
on
OCT
23
Nature Reviews Cardiology, Published online: 23 October 2024; doi:10.1038/s41569-024-01092-0In this Tools of the Trade article, Bodagh and Williams highlight the utility of OpenEP, an open-source platform that offers standardized solutions for storage and analysis of electroanatomic mapping data.
Read more >>
Weitere Beiträge
Clinical Oncology
NOV
12
First-line triplet therapy for advanced-stage
PIK3CA
-mutant HR
+
breast cancer improves outcomes
By:
David Killock
on
NOV
12
Nature Reviews Clinical Oncology, Published online: 12 November 2024; doi:10.1038/s41571-024-00968-xFirst-line triplet therapy for advanced-stage PIK3CA-mutant HR+ breast cancer improves outcomes
Read more >>
NOV
06
Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?
By:
Joshua Drago
on
NOV
06
Nature Reviews Clinical Oncology, Published online: 06 November 2024; doi:10.1038/s41571-024-00963-2The DESTINY-Breast06 trial investigated earlier and broader use of trastuzumab deruxtecan in patients with metastatic hormone-receptor-positive breast cancer, and demonstrated improvements in progression-free survival over standard chemotherapy. These data provide a meaningful advance; however, this strategy might not be right for all patients, and careful consideration is recommended before blanket use.
Read more >>
NOV
05
On the cusp of targeted therapy for cancer cachexia — what clinical benefits might we promise our patients?
By:
Vickie E. Baracos
on
NOV
05
Nature Reviews Clinical Oncology, Published online: 05 November 2024; doi:10.1038/s41571-024-00964-1A number of therapeutics that target mediators of signalling in the hypothalamic and brainstem regions that control appetite, ingestive behaviour, satiety, nausea and vomiting are starting to move the needle on cancer cachexia. However, clarification of meaningful clinical benefits for patients and the primary end points that should support regulatory approval of cachexia treatments is needed.
Read more >>
NOV
01
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
By:
Michele D. Stanchina
on
NOV
01
Nature Reviews Clinical Oncology, Published online: 01 November 2024; doi:10.1038/s41571-024-00956-1In several B cell malignancies, BTK is a crucial mediator of oncogenic signalling pathways and inhibitors of this kinase have substantially improved patient outcomes. This Review discusses the currently approved indications for covalent and non-covalent BTK inhibitors, as well as mechanisms of resistance, and novel BTK-targeted agents and treatment strategies that have the potential to further improve outcomes.
Read more >>
OCT
30
Author Correction: The high costs of anticancer therapies in the USA: challenges, opportunities and progress
By:
Shelley A. Jazowski
on
OCT
30
Nature Reviews Clinical Oncology, Published online: 30 October 2024; doi:10.1038/s41571-024-00958-zAuthor Correction: The high costs of anticancer therapies in the USA: challenges, opportunities and progress
Read more >>
OCT
25
Cadonilimab is effective and safe in recurrent cervical cancer
By:
Diana Romero
on
OCT
25
Nature Reviews Clinical Oncology, Published online: 25 October 2024; doi:10.1038/s41571-024-00962-3Cadonilimab is effective and safe in recurrent cervical cancer
Read more >>
OCT
25
NALIRIFOX in the frontline for metastatic pancreatic cancer: evidence beyond NAPOLI 3
By:
Zev A. Wainberg
on
OCT
25
Nature Reviews Clinical Oncology, Published online: 25 October 2024; doi:10.1038/s41571-024-00952-5NALIRIFOX in the frontline for metastatic pancreatic cancer: evidence beyond NAPOLI 3
Read more >>
OCT
25
Reply to ‘NALIRIFOX in the frontline for metastatic pancreatic cancer: evidence beyond NAPOLI 3’
By:
Christopher Nevala-Plagemann
on
OCT
25
Nature Reviews Clinical Oncology, Published online: 25 October 2024; doi:10.1038/s41571-024-00953-4Reply to ‘NALIRIFOX in the frontline for metastatic pancreatic cancer: evidence beyond NAPOLI 3’
Read more >>
Weitere Beiträge
Endocrinology
NOV
13
Growth hormone-releasing hormone and its analogues in health and disease
By:
Riccarda Granata
on
NOV
13
Nature Reviews Endocrinology, Published online: 13 November 2024; doi:10.1038/s41574-024-01052-1Growth hormone-releasing hormone (GHRH) signalling modulation has shown beneficial effects in a wide range of diseases in preclinical research. This Review discusses the progression of research into the effects of GHRH agonist and antagonist treatment in several contexts, including cancer, inflammation, cardiovascular disease and metabolism.
Read more >>
NOV
11
Autologous stem-cell derived islets — the ultimate frontier in diabetes mellitus?
By:
A. M. James Shapiro
on
NOV
11
Nature Reviews Endocrinology, Published online: 11 November 2024; doi:10.1038/s41574-024-01064-xA patient with longstanding type 1 diabetes mellitus has achieved insulin independence for at least 1 year after transplantation of autologous stem cell islets. These cells were differentiated from inducible pluripotent stem cells from adipose tissue and were transplanted into the rectus sheath of the abdominal wall.
Read more >>
NOV
08
Macrophages support pancreatic development
By:
Senegal Carty
on
NOV
08
Nature Reviews Endocrinology, Published online: 08 November 2024; doi:10.1038/s41574-024-01062-zMacrophages support pancreatic development
Read more >>
NOV
08
Highlights from the Joint Irish–UK Endocrine Meeting 2024
By:
Olivia Tysoe
on
NOV
08
Nature Reviews Endocrinology, Published online: 08 November 2024; doi:10.1038/s41574-024-01065-wHighlights from the Joint Irish–UK Endocrine Meeting 2024
Read more >>
NOV
08
IL-17 has a role in whole-body homeostasis
By:
Claire Greenhill
on
NOV
08
Nature Reviews Endocrinology, Published online: 08 November 2024; doi:10.1038/s41574-024-01063-yIL-17 has a role in whole-body homeostasis
Read more >>
NOV
05
Intricacies and obscurities of non-shivering thermogenesis
By:
Anand Kumar Sharma
on
NOV
05
Nature Reviews Endocrinology, Published online: 05 November 2024; doi:10.1038/s41574-024-01060-1Intricacies and obscurities of non-shivering thermogenesis
Read more >>
NOV
04
Looking back at the TEDDY study: lessons and future directions
By:
Åke Lernmark
on
NOV
04
Nature Reviews Endocrinology, Published online: 04 November 2024; doi:10.1038/s41574-024-01045-0This Review outlines the screening, enrolment and recruitment challenges in the TEDDY (The Environmental Determinants of Diabetes in the Young) study. The key findings related to the first primary end point are discussed, and future directions of study are highlighted.
Read more >>
OCT
28
Our future, we decide: five ways to reform the scientific publication process
By:
Morten Dall
on
OCT
28
Nature Reviews Endocrinology, Published online: 28 October 2024; doi:10.1038/s41574-024-01056-xAlthough science is becoming ever more complex, interdisciplinary and open, the scientific publication process has largely remained static, which affects the integrity and impact of articles. At the 2023 Danish Diabetes and Endocrine Academy Postdoc Summit, we identified five aspects of this process that need attention to enable reform.
Read more >>
Weitere Beiträge
GI and Hepatology
NOV
11
A new treatment and updated clinical practice guidelines for MASLD
By:
Elizabeth E. Powell
on
NOV
11
Nature Reviews Gastroenterology & Hepatology, Published online: 11 November 2024; doi:10.1038/s41575-024-01014-yThe year 2024 was momentous for metabolic dysfunction-associated steatotic liver disease (MASLD): the approval of the first medication for treatment of at-risk metabolic dysfunction-associated steatohepatitis, updated guidelines on the screening, diagnosis and treatment of MASLD, and liver stiffness measurement as an important surrogate marker for liver-related outcomes in MASLD.
Read more >>
NOV
11
Metabolic health across the ages: how microbiota members support our well-being
By:
Carolina Tropini
on
NOV
11
Nature Reviews Gastroenterology & Hepatology, Published online: 11 November 2024; doi:10.1038/s41575-024-01004-0The microbiota is critical for metabolic health. Studies published in 2024 have revealed mechanisms by which key bacterial and micro-eukaryotic organisms optimize energy production in our body and ensure efficient metabolic function.
Read more >>
NOV
04
Probiotics for preterms: sharing complex decision-making
By:
Geoffrey A. Preidis
on
NOV
04
Nature Reviews Gastroenterology & Hepatology, Published online: 04 November 2024; doi:10.1038/s41575-024-01009-9Probiotics might prevent some necrotizing enterocolitis, late-onset sepsis and mortality in preterm infants. However, clinical practice varies widely, and families are often excluded from shared decision making. This Clinical Outlook highlights current evidence, clinical practice guidelines and the future outlook of probiotics in the neonatal intensive care unit.
Read more >>
NOV
04
Transport functions of intestinal lymphatic vessels
By:
Patrick Tso
on
NOV
04
Nature Reviews Gastroenterology & Hepatology, Published online: 04 November 2024; doi:10.1038/s41575-024-00996-zLymphatic vessels are important for fluid absorption and immune cell transport. This Review discusses the role of the intestinal lymphatic system in transport and inter-organ communication, exploring lipid absorption mechanisms, gut microenvironment influences, immune cell trafficking and intestinal lymphatics as a drug delivery system.
Read more >>
OCT
31
Health disparities in cirrhosis care and liver transplantation
By:
David Goldberg
on
OCT
31
Nature Reviews Gastroenterology & Hepatology, Published online: 31 October 2024; doi:10.1038/s41575-024-01003-1Cirrhosis morbidity and mortality are rising worldwide, with health disparities affecting minorities, people of low socioeconomic status, and underserved rural communities. This Review addresses inequities in cirrhosis management and liver transplantation, highlighting the immediate necessity for improving health equity.
Read more >>
OCT
30
Gut microbiome: a biomedical revolution
By:
Maria Carmen Collado
on
OCT
30
Nature Reviews Gastroenterology & Hepatology, Published online: 30 October 2024; doi:10.1038/s41575-024-01001-3In this Viewpoint, Maria Carmen Collado, Suzanne Devkota and Tarini Shankar Ghosh comment on the past and future of gut microbiome research and clinical applications.
Read more >>
OCT
29
Intestinal tuft cells can act as injury-resistant stem cells
By:
Caroline Barranco
on
OCT
29
Nature Reviews Gastroenterology & Hepatology, Published online: 29 October 2024; doi:10.1038/s41575-024-01016-wIntestinal tuft cells can act as injury-resistant stem cells
Read more >>
OCT
28
Bitter taste receptors as sensors of gut luminal contents
By:
Catia Sternini
on
OCT
28
Nature Reviews Gastroenterology & Hepatology, Published online: 28 October 2024; doi:10.1038/s41575-024-01005-zType 2 taste receptors (Tas2rs in mice and TAS2Rs in humans) detect bitter stimuli and are present in both the oral cavity and extraoral sites. In this Review, the authors discuss Tas2rs/TAS2Rs in the gastrointestinal enteroendocrine system and how they could be potential targets to prevent or treat metabolic disorders.
Read more >>
Weitere Beiträge
Nephrology
NOV
05
Kidney disease and reproductive health
By:
Priscilla A. Smith
on
NOV
05
Nature Reviews Nephrology, Published online: 05 November 2024; doi:10.1038/s41581-024-00901-6The authors review the effect of chronic kidney disease (CKD) on female and male fertility and pregnancy outcomes. They also discuss the risk of pregnancy-associated CKD progression and the potential effect of maternal or paternal CKD on the offspring.
Read more >>
OCT
30
ECM remodelling by ADAMTS12 in fibrosis
By:
Susan J. Allison
on
OCT
30
Nature Reviews Nephrology, Published online: 30 October 2024; doi:10.1038/s41581-024-00905-2ECM remodelling by ADAMTS12 in fibrosis
Read more >>
OCT
23
A guide to gene–disease relationships in nephrology
By:
Zornitza Stark
on
OCT
23
Nature Reviews Nephrology, Published online: 23 October 2024; doi:10.1038/s41581-024-00900-7The catalogue of genetic factors that have been implicated in kidney disease continues to grow. In this guide to gene–disease relationships, the authors discuss the crucial process whereby genetic and experimental data are critically evaluated to determine whether a genetic variant has a role in kidney disease, which can affect patient diagnosis, prognosis and management.
Read more >>
OCT
22
Treating AAV by targeting T cell responses
By:
Monica Wang
on
OCT
22
Nature Reviews Nephrology, Published online: 22 October 2024; doi:10.1038/s41581-024-00904-3Treating AAV by targeting T cell responses
Read more >>
OCT
22
Bacteria caught in neutrophil and UMOD traps in urine
By:
Monica Wang
on
OCT
22
Nature Reviews Nephrology, Published online: 22 October 2024; doi:10.1038/s41581-024-00903-4Bacteria caught in neutrophil and UMOD traps in urine
Read more >>
OCT
22
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)
By:
Elena Levtchenko
on
OCT
22
Nature Reviews Nephrology, Published online: 22 October 2024; doi:10.1038/s41581-024-00897-zCongenital nephrogenic diabetes insipidus is a rare but potentially life-threatening condition. This Consensus Statement provides clinical practice recommendations developed by the European Reference Network on Rare Kidney Diseases, the European Society for Paediatric Nephrology and patient advocates to support clinicians in the diagnosis, treatment and genetic counselling of children and adults with nephrogenic diabetes insipidus.
Read more >>
OCT
15
A guide to studying 3D genome structure and dynamics in the kidney
By:
Brian J. Beliveau
on
OCT
15
Nature Reviews Nephrology, Published online: 15 October 2024; doi:10.1038/s41581-024-00894-2Here, the authors describe approaches to investigating 3D genome architecture and dynamics. They discuss the physical organization and dynamic regulation of the genome and highlight studies that have provided insights into the roles of genome structure and regulation in kidney health and disease.
Read more >>
OCT
03
Multidisciplinary collaboration to improve neonatal kidney health
By:
Jennifer R. Charlton
on
OCT
03
Nature Reviews Nephrology, Published online: 03 October 2024; doi:10.1038/s41581-024-00895-1The Neonatal Kidney Collaborative is a multidisciplinary initiative that aims to improve neonatal kidney health. By uniting experts and promoting trainees from various fields, the collaborative has developed a strong foundation for research, education and advocacy efforts that will advance our understanding and treatment of kidney problems in newborns.
Read more >>
Weitere Beiträge
Neurology
NOV
13
Glymphatic dysfunction in PD clinical progression
By:
Lisa Kiani
on
NOV
13
Nature Reviews Neurology, Published online: 13 November 2024; doi:10.1038/s41582-024-01040-zGlymphatic dysfunction in PD clinical progression
Read more >>
NOV
13
Dementia risk scores in diverse populations
By:
Lisa Kiani
on
NOV
13
Nature Reviews Neurology, Published online: 13 November 2024; doi:10.1038/s41582-024-01039-6Dementia risk scores in diverse populations
Read more >>
NOV
13
High prevalence of hepatitis B in NMOSD
By:
Lisa Kiani
on
NOV
13
Nature Reviews Neurology, Published online: 13 November 2024; doi:10.1038/s41582-024-01037-8High prevalence of hepatitis B in NMOSD
Read more >>
NOV
13
Immune responses influence sex differences in Alzheimer disease
By:
Ian Fyfe
on
NOV
13
Nature Reviews Neurology, Published online: 13 November 2024; doi:10.1038/s41582-024-01044-9Sex differences in Alzheimer disease could be influenced by differences in immune responses, new research suggests.
Read more >>
NOV
13
Oligodendrocyte progenitor cell transplant for MS
By:
Lisa Kiani
on
NOV
13
Nature Reviews Neurology, Published online: 13 November 2024; doi:10.1038/s41582-024-01038-7Oligodendrocyte progenitor cell transplant for MS
Read more >>
NOV
04
Parkinson disease therapy: current strategies and future research priorities
By:
Fabrizio Stocchi
on
NOV
04
Nature Reviews Neurology, Published online: 04 November 2024; doi:10.1038/s41582-024-01034-xParkinson disease (PD) poses substantial management challenges owing to progressive disability and emergence of levodopa-resistant symptoms and treatment-related complications. This Review examines the current state of research into symptomatic and disease-modifying PD therapies and outlines future priorities for advancing our understanding and treatment of the disease.
Read more >>
OCT
25
The Digitized Memory Clinic
By:
Mathias Holsey Gramkow
on
OCT
25
Nature Reviews Neurology, Published online: 25 October 2024; doi:10.1038/s41582-024-01033-yIn this Perspective, the authors present the Digitized Memory Clinic, a new framework for the diagnostic pathway of neurodegenerative dementias that incorporates digital health technologies with currently available assessment tools, such as fluid and imaging biomarkers, in an interplay with the physician.
Read more >>
OCT
14
BCAS1
+
oligodendrocytes aid remyelination in MS
By:
Heather Wood
on
OCT
14
Nature Reviews Neurology, Published online: 14 October 2024; doi:10.1038/s41582-024-01031-0BCAS1+ oligodendrocytes aid remyelination in MS
Read more >>
Weitere Beiträge
Rheumatology
NOV
13
Publisher Correction: Recent advances in the diagnosis and management of neuropsychiatric lupus
By:
Alexandra C. Legge
on
NOV
13
Nature Reviews Rheumatology, Published online: 13 November 2024; doi:10.1038/s41584-024-01193-7Publisher Correction: Recent advances in the diagnosis and management of neuropsychiatric lupus
Read more >>
NOV
07
The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus
By:
Thomas Dörner
on
NOV
07
Nature Reviews Rheumatology, Published online: 07 November 2024; doi:10.1038/s41584-024-01179-5BCR-independent memory B cell reactivation via TLR7 or TLR8 activation, type I interferon production, immune complex formation and T helper cell signalling is central in SLE pathogenesis. Dörner and Lipsky discuss the potential of targeting these pathways to eliminate autoreactive memory B cells and plasma cells in SLE.
Read more >>
NOV
06
The management of adult and paediatric uveitis for rheumatologists
By:
Sarah L. N. Clarke
on
NOV
06
Nature Reviews Rheumatology, Published online: 06 November 2024; doi:10.1038/s41584-024-01181-xThis Review provides an overview of the pathogenesis, classification and diagnosis of and treatment strategies for adult and paediatric rheumatology patients with uveitis. The authors highlight the importance of collaborations between ophthalmologists and rheumatologists to provide optimal treatment of uveitis, improve patient care and enhance future research.
Read more >>
NOV
05
Dupuytren contracture treatments compared
By:
Sarah Onuora
on
NOV
05
Nature Reviews Rheumatology, Published online: 05 November 2024; doi:10.1038/s41584-024-01186-6In an open-label clinical trial, collagenase injection was not noninferior to limited fasciectomy for the treatment of Dupuytren contracture.
Read more >>
NOV
04
Novel autoantigen in idiopathic lung disease
By:
Maria Papatriantafyllou
on
NOV
04
Nature Reviews Rheumatology, Published online: 04 November 2024; doi:10.1038/s41584-024-01187-5The presence of anti-IFI16 autoantibodies in patients with idiopathic interstitial pneumonia is linked to poor prognosis and could inform treatment.
Read more >>
OCT
31
Risk of uveitis in SpA is changing
By:
Sarah Onuora
on
OCT
31
Nature Reviews Rheumatology, Published online: 31 October 2024; doi:10.1038/s41584-024-01185-7Findings from an observational study suggest that the frequency of uveitis in patients with spondyloarthritis has declined since the introduction of biologic DMARDs.
Read more >>
OCT
31
Rheumatology in the digital health era: status quo and quo vadis?
By:
Johannes Knitza
on
OCT
31
Nature Reviews Rheumatology, Published online: 31 October 2024; doi:10.1038/s41584-024-01177-7Digital health has the potential to improve patient care in rheumatology and alleviate strain on the health-care system. This Review explores the current status of the transition from traditional health care to a model that harnesses the potential of digital health technologies, including discussion of the main benefits and barriers.
Read more >>
OCT
30
Rheumatic diseases and metabolism: where centre and periphery meet
By:
Miguel López
on
OCT
30
Nature Reviews Rheumatology, Published online: 30 October 2024; doi:10.1038/s41584-024-01178-6In this Review, López and Gualillo discuss the complex interrelationships between rheumatic diseases and the hypothalamic and autonomic mechanisms that regulate metabolism, and explore the therapeutic potential of targeting central regulators of energy balance.
Read more >>
Weitere Beiträge
Urology
NOV
14
Disruption of circadian rhythm as a potential pathogenesis of nocturia
By:
Qi-Xiang Song
on
NOV
14
Nature Reviews Urology, Published online: 14 November 2024; doi:10.1038/s41585-024-00961-0The circadian rhythm has a crucial role in regulating nocturia. In this Review, the authors discuss how the brain–kidney–bladder circadian axis can lead to nocturia, prompted by the rationale that understanding these disruptions can lead to developing effective treatments targeting circadian rhythms.
Read more >>
NOV
14
Molecular imaging of renal cell carcinomas: ready for prime time
By:
Qianyun Wu
on
NOV
14
Nature Reviews Urology, Published online: 14 November 2024; doi:10.1038/s41585-024-00962-zIn this Review, the authors provide an overview of molecular imaging in renal cell carcinoma, discussing the role of molecular imaging approaches in renal cell carcinoma diagnosis, treatment and response monitoring.
Read more >>
NOV
14
HSD3B1
, prostate cancer mortality and modifiable outcomes
By:
Pedro F. S. Freitas
on
NOV
14
Nature Reviews Urology, Published online: 14 November 2024; doi:10.1038/s41585-024-00953-0A common germline missense-encoding polymorphism in HSD3B1, called the adrenal-permissive allele, facilitates androgen synthesis from adrenal precursors via increased 3β-hydroxysteroid dehydrogenase 1 (3βHSD1). Here, the authors focus on mechanistic and clinical investigations of 3βHSD1 and the clinical consequences and potential utility of detecting adrenal-permissive allele inheritance.
Read more >>
NOV
13
Metabolism, mitochondria and metastasis in kidney cancer
By:
Louise Lloyd
on
NOV
13
Nature Reviews Urology, Published online: 13 November 2024; doi:10.1038/s41585-024-00968-7Metabolism, mitochondria and metastasis in kidney cancer
Read more >>
NOV
11
177
Lu-PSMA-617 extends progression-free survival in taxane-naive mCRPC
By:
Maria Chiara Masone
on
NOV
11
Nature Reviews Urology, Published online: 11 November 2024; doi:10.1038/s41585-024-00970-z177Lu-PSMA-617 extends progression-free survival in taxane-naive mCRPC
Read more >>
NOV
11
Tivozanib monotherapy outperforms combination therapy in post-ICI RCC
By:
Maria Chiara Masone
on
NOV
11
Nature Reviews Urology, Published online: 11 November 2024; doi:10.1038/s41585-024-00971-yTivozanib monotherapy outperforms combination therapy in post-ICI RCC
Read more >>
NOV
11
The urge to advance: ICS 2024 drives innovation in continence care
By:
Maria Chiara Masone
on
NOV
11
Nature Reviews Urology, Published online: 11 November 2024; doi:10.1038/s41585-024-00972-xThe urge to advance: ICS 2024 drives innovation in continence care
Read more >>
NOV
11
Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects
By:
Tania E. Saez Lancellotti
on
NOV
11
Nature Reviews Urology, Published online: 11 November 2024; doi:10.1038/s41585-024-00952-1High-fat diets disrupt testicular function by accumulating lipids, impairing sperm production and affecting the cytoskeleton of spermatogenic cells. This Perspective aims to understand these mechanisms to develop treatments for infertility in men with obesity.
Read more >>
Weitere Beiträge
Share
Tweet
Share
Mail
English version of this site is mostly translated automatically using "google translate". In case of language difficulties please do not hesitate to contact me.
Share by: